findmyKOL
Clinical trialNCT07060508CompletedPhase 2Interventional

L9LS in Women of Childbearing Potential in Mali

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment279Malaria
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Safety and Efficacy of L9LS, a Human Monoclonal Antibody Against Plasmodium falciparum, in a Randomized, Double-Blind, Placebo-Controlled Trial of Women of Childbearing Potential (WOCBP) in Mali
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Kassoum Kayentao, MD, MPH, PhD

    Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)

    Principal Investigator
    clinicaltrials.gov ↗
  • Peter Crompton, MD, MPH

    National Institutes of Health (NIH)

    Principal Investigator
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Mali
  • Faladje Mrtc Clinic

    Faladié, Koulikoro, Mali

  • Kalifabougou Mrtc Clinic

    Kalifabougou, Koulikoro, Mali

  • Torodo Mrtc Clinic

    Torodo, Koulikoro, Mali

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Single dose of 1800 mg L9LS SC
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Jul 2025
Primary completion
13 Apr 2026
Completion
13 Apr 2026
Last update posted
10 Jun 2026
Registered enrollment
279
Registry id
NCT07060508
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.